Skip to main content
Signal8

KEYSER D JEFFREY

SEC insider (Form 3/4/5 filer). CIK 0001393516. Director at Lantern Pharma Inc. (LTRN). 7 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in DALLAS, TX.

Companies KEYSER D JEFFREY has filed insider reports for

  • Lantern Pharma Inc. (LTRN): Director
KEYSER D JEFFREY profile photo

KEYSER D JEFFREY

CIK: 0001393516

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lantern Pharma Inc. logo
LTRN

Lantern Pharma Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    May 12, 2026
    Purchase
    Direct
    48.5K shares at avg. $2.06$100K
  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    Jan 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    28.8K shares-
  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    Jan 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    25K shares-
  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    Nov 4, 2021
    Disposition

    Stock Option (Right to Buy)

    Direct
    3.2K shares-
  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    Nov 4, 2021
    Award

    Stock Option (Right to Buy)

    Direct
    3.2K shares-
  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    Jun 15, 2020
    Disposition

    Stock Option (Right to Buy)

    Direct
    9.1K shares-
  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    Jun 15, 2020
    Award

    Stock Option (Right to Buy)

    Direct
    9.1K shares-

1-7 of 7